Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Study Examines Impact of Varying COVID-19 Vaccination Rates on Population-Level Health Outcomes in the U.S.

In a recent study published in BMC Public Health, researchers examined the impact of varying COVID-19 vaccination rates on population-level health outcomes across different waves of the virus in the United States. The study focused on the association between time-varying COVID-19 vaccination rates and COVID-19 case-hospitalization risk (CHR), which serves as a proxy for disease severity at an individual level and the burden on healthcare systems at the population level.

Background

By March 1, 2023, COVID-19 had resulted in 1.1 million deaths in the U.S. The effectiveness of COVID-19 vaccines in mitigating the disease and its impact, including the socioeconomic burden and strain on the healthcare system, has been well-documented. However, previous studies assessing vaccine effectiveness were based on individual-level data affected by unquantified factors and inconsistent quality. This led to a lack of high-resolution population-level data in the U.S., hindering the understanding of the real-world associations between available COVID-19 vaccines and COVID-19 CHR over time.

About the Study

The study utilized Generalized Additive Models (GAMs) to explore the relationship between COVID-19 vaccination rates and CHR across 48 U.S. states from April 19, 2021, to March 1, 2022. The model considered dynamic and static factors, including natural immunity from previous SARS-CoV-2 infection, government policies, population engagement levels, local healthcare infrastructure, social vulnerability index (SVI), race/ethnicity, comorbidities, and healthcare expenditures of each state. Additionally, the study examined COVID-19 case incidence rates (CIR) as a separate outcome variable, capturing spatial variations in relative associations. The study period encompassed the pre-Delta, Delta, and Omicron waves of COVID-19, evaluating each independently.

Results

The study revealed several significant findings regarding the effects of COVID-19 vaccines on population-level health outcomes in the U.S. The GAMs demonstrated the relative associations between COVID-19 vaccination rates and CHR, shedding light on the impact of vaccination rates on disease severity and healthcare system burden across different SARS-CoV-2 variant waves.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *